Author

Eszter Schäfer 1

1 HDF Medical Centre,Budapest,Hungary

CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY

Lorant Gonczi, Kata Szántó, Klaudia Farkas, Tamás Molnár, Tamás Szamosi, Eszter Schäfer, Petra Anna Golovics, Barbara Dorottya Lovasz, Mark Juhasz, Árpád V. Patai, Aron Vincze, Patrícia Sarlós, Karoly Palatka, Alexandra Farkas, Gábor Tamás Tóth, Peter L Lakatos, Pal Miheller, Ákos Iliás

FERTILITY AND PREGNANCY IN IBD - OUR EXPERIENCES

Eszter Schäfer

FERTILITY AND PREGNANCY IN IBD - OUR EXPERIENCES

Eszter Schäfer, Klára Bursics, Tamás Szamosi, János Banai, Ferenc Zsigmond, Tibor Zoltán Gyökeres, László Herszényi

IBD-RELATED MALIGNANCIES AND MORTALITIES OBSERVED BETWEEN 2015-2016 – TWO YEARS’ RESULTS FROM THE PROSPECTIVE NATIONWIDE HUNGARIAN REGISTRY

Tamás Molnár, Mariann Rutka, Ferenc Nagy, Péter Fritz, László Lakatos, Pal Miheller, Zsuzsanna Erdelyi, Tamás Szamosi, Eszter Schäfer, Aron Vincze, Patrícia Sarlós, János Banai, Ágota Kovács, János Novák, Ágnes Szabone Salamon, Attila Szepes, Nora Szigeti, Mark Juhasz, Katalin Müllner, Zsolt Barta, Orsolya Kadenczki, A

LONG-TERM EFFICACY OF VEDOLIZUMAB THERAPY ON CLINICAL AND ENDOSCOPIC ACTIVITY IN PATIENTS WITH ANTI-TUMOR NECROSIS FACTOR ALPHA RESISTANT INFLAMMATORY BOWEL DISEASE

Renáta Bor, Zoltan Gabor Szepes, Mária Matuz, Klaudia Farkas, Anna Fabian, Pal Miheller, Karoly Palatka, Tamás Szamosi, Aron Vincze, Lilla Laura Lakner, Katalin Müllner, Mária Papp, Ágnes Szabone Dr Salamon, Eszter Schäfer, Krisztina Fülöpné Sarang, Ferenc Nagy, Ferenc Zsigmond, János Banai, Kata Szántó, Anita Balint, M

NON-MEDICAL, MANDATORY SWITCH AMONG ADALIMUMAB BIOSIMILARS AND FROM THE ORIGINATOR ADALIMUMAB TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS – A PROSPECTIVE, MULTICENTRE STUDY ON EFFICACY, DRUG SUSTAINABILITY AND SAFETY

Livia Lontai, Lorant Gonczi, Fruzsina Balogh, Nora Komlodi, Tamás Resál, Klaudia Farkas, Tamás Molnár, Pal Miheller, Petra Anna Golovics, Eszter Schäfer, Tamás Szamosi, Ákos Iliás, Peter L Lakatos

Short- and long-term efficacy of vedolizumab therapy on clinical and endoscopic activity in patients with anti-tumor necrosis factor alpha resistant inflammatory bowel disease

Renáta Bor, Klaudia Farkas, Pal Miheller, Karoly Palatka, Tamás Szamosi, Aron Vincze, Mária Matuz, Mariann Rutka, Kata Szántó, Tibor Tóth, Anita Balint, Szepes Zoltán, Ferenc Nagy, Ágnes Milassin, Anna Fabian, Ferenc Zsigmond, Judit Bajor, Lilla Laura Lakner, Müllner Katalin, Katalin Müllner, Mária Papp, Ágnes Szabone

USTEKINUMAB IS ASSOCIATED WITH SUPERIOR TREATMENT PERSISTENCE BUT NOT WITH HIGHER REMISSION RATES COMPARED TO VEDOLIZUMAB IN REFRACTORY CROHN’S DISEASE PATIENTS: RESULTS FROM A MULTICENTRE COHORT STUDY

Péter Bacsur, Mária Matuz, Tamás Resál, Pal Miheller, Tamás Szamosi, Eszter Schäfer, Patrícia Sarlós, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Balint, Ágnes Milassin, Anna Fabian, Renáta Bor, Szepes Zoltán, Tamás Molnár, Klaudia Farkas

Item 1 - 8 / 10
1